effect
→
ReceivesAction
→
determined
|
0.65
|
|
effect
→
ReceivesAction
→
felt
|
0.64
|
|
effect
→
ReceivesAction
→
achieved
|
0.60
|
|
effect
→
ReceivesAction
→
understood
|
0.59
|
|
effect
→
ReceivesAction
→
studied
|
0.59
|
|
effect
→
ReceivesAction
→
reduced
|
0.58
|
|
effect
→
ReceivesAction
→
avoided
|
0.56
|
|
effect
→
ReceivesAction
→
limited
|
0.55
|
|
effect
→
ReceivesAction
→
treated
|
0.54
|
|
effect
→
ReceivesAction
→
decreased
|
0.54
|
|
effect
→
ReceivesAction
→
reported to the fda
|
0.53
|
|
effect
→
ReceivesAction
→
increased
|
0.53
|
|
effect
→
ReceivesAction
→
monitored
|
0.53
|
|
effect
→
ReceivesAction
→
explored
|
0.52
|
|
effect
→
ReceivesAction
→
managed
|
0.52
|
|
effect
→
ReceivesAction
→
seen in patient
|
0.52
|
|
effect
→
ReceivesAction
→
related
|
0.52
|
|
effect
→
ReceivesAction
→
provided
|
0.52
|
|
effect
→
ReceivesAction
→
reviewed
|
0.51
|
|
effect
→
ReceivesAction
→
eliminated
|
0.51
|
|
effect
→
ReceivesAction
→
associated with chemotherapy
|
0.51
|
|
effect
→
ReceivesAction
→
minimized
|
0.50
|
|
effect
→
ReceivesAction
→
reversed
|
0.50
|
|
effect
→
ReceivesAction
→
likely to occur
|
0.49
|
|
effect
→
ReceivesAction
→
observed in study
|
0.49
|
|
effect
→
ReceivesAction
→
caused by drug
|
0.49
|
|
effect
→
ReceivesAction
→
seen with drug
|
0.48
|
|
effect
→
ReceivesAction
→
associated with the drug
|
0.48
|
|
effect
→
ReceivesAction
→
experienced by patient
|
0.47
|
|
effect
→
ReceivesAction
→
produced by the drug
|
0.47
|
|
effect
→
ReceivesAction
→
controlled
|
0.46
|
|
effect
→
ReceivesAction
→
alleviated
|
0.46
|
|
effect
→
ReceivesAction
→
caused by steroid
|
0.46
|
|
effect
→
ReceivesAction
→
expected
|
0.45
|
|
effect
→
ReceivesAction
→
amplified
|
0.45
|
|
effect
→
ReceivesAction
→
altered
|
0.45
|
|
effect
→
ReceivesAction
→
described
|
0.45
|
|
effect
→
ReceivesAction
→
reported
|
0.44
|
|
effect
→
ReceivesAction
→
mitigated
|
0.44
|
|
effect
→
ReceivesAction
→
delayed
|
0.44
|
|
effect
→
ReceivesAction
→
enhanced
|
0.43
|
|
effect
→
ReceivesAction
→
manifested
|
0.43
|
|
effect
→
ReceivesAction
→
reported to the doctor
|
0.43
|
|
effect
→
ReceivesAction
→
difficult to predict
|
0.43
|
|
effect
→
ReceivesAction
→
associated with medication
|
0.43
|
|
effect
→
ReceivesAction
→
shown in table
|
0.43
|
|
effect
→
ReceivesAction
→
reported by patient
|
0.42
|
|
effect
→
ReceivesAction
→
lived
|
0.42
|
|
effect
→
ReceivesAction
→
taken into account
|
0.41
|
|
effect
→
ReceivesAction
→
attributed
|
0.41
|
|
effect
→
ReceivesAction
→
observed
|
0.41
|
|
effect
→
ReceivesAction
→
noted
|
0.41
|
|
effect
→
ReceivesAction
→
documented
|
0.41
|
|
effect
→
ReceivesAction
→
tolerated
|
0.40
|
|
effect
→
ReceivesAction
→
overcome
|
0.40
|
|
effect
→
ReceivesAction
→
associated with treatment
|
0.40
|
|
effect
→
ReceivesAction
→
associated with long-term use
|
0.39
|
|
effect
→
ReceivesAction
→
caused
|
0.39
|
|
effect
→
ReceivesAction
→
under-reported
|
0.39
|
|
effect
→
ReceivesAction
→
mediated
|
0.38
|
|
effect
→
ReceivesAction
→
studied in mouse
|
0.38
|
|
effect
→
ReceivesAction
→
associated with older drugs
|
0.38
|
|
effect
→
ReceivesAction
→
reported by user
|
0.38
|
|
effect
→
ReceivesAction
→
seen in child
|
0.38
|
|
effect
→
ReceivesAction
→
lost
|
0.38
|
|
effect
→
ReceivesAction
→
reported by participant
|
0.38
|
|
effect
→
ReceivesAction
→
seen in dog
|
0.38
|
|
effect
→
ReceivesAction
→
dramatic to say the
|
0.38
|
|
effect
→
ReceivesAction
→
maintained
|
0.38
|
|
effect
→
ReceivesAction
→
prolonged
|
0.38
|
|
effect
→
ReceivesAction
→
exacerbated
|
0.37
|
|
effect
→
ReceivesAction
→
improved
|
0.37
|
|
effect
→
ReceivesAction
→
required
|
0.37
|
|
effect
→
ReceivesAction
→
obtained
|
0.37
|
|
effect
→
ReceivesAction
→
tested
|
0.37
|
|
effect
→
ReceivesAction
→
associated with opioid
|
0.36
|
|
effect
→
ReceivesAction
→
studied in rat
|
0.36
|
|
effect
→
ReceivesAction
→
desired
|
0.36
|
|
effect
→
ReceivesAction
→
balanced with potential benefits
|
0.36
|
|
effect
→
ReceivesAction
→
proven
|
0.36
|
|
effect
→
ReceivesAction
→
reported in trial
|
0.35
|
|
effect
→
ReceivesAction
→
blocked
|
0.35
|
|
effect
→
ReceivesAction
→
studied in rabbit
|
0.35
|
|
effect
→
ReceivesAction
→
seen in people
|
0.35
|
|
effect
→
ReceivesAction
→
associated with effexor
|
0.35
|
|
effect
→
ReceivesAction
→
discovered
|
0.35
|
|
effect
→
ReceivesAction
→
studied for many years
|
0.34
|
|
effect
→
ReceivesAction
→
studied in 10 healthy subjects
|
0.34
|
|
effect
→
ReceivesAction
→
associated with antihistamine
|
0.34
|
|
effect
→
ReceivesAction
→
aimed
|
0.34
|
|
effect
→
ReceivesAction
→
achieved at lower doses
|
0.33
|
|
effect
→
ReceivesAction
→
caused by improper use of the m…
|
0.33
|
|
effect
→
ReceivesAction
→
explained
|
0.33
|
|
effect
→
ReceivesAction
→
seen in athlete
|
0.33
|
|
effect
→
ReceivesAction
→
shown in figure
|
0.33
|
|
effect
→
ReceivesAction
→
managed by dosage adjustments
|
0.33
|
|
effect
→
ReceivesAction
→
associated with amantadine
|
0.32
|
|
effect
→
ReceivesAction
→
associated with phentermine
|
0.32
|
|
effect
→
ReceivesAction
→
treated with additional medicat…
|
0.32
|
|
effect
→
ReceivesAction
→
based
|
0.32
|
|
effect
→
ReceivesAction
→
compared to placebo
|
0.32
|
|
effect
→
ReceivesAction
→
weakened
|
0.32
|
|
effect
→
ReceivesAction
→
stopped
|
0.32
|
|
effect
→
ReceivesAction
→
associated with other applicati…
|
0.31
|
|
effect
→
ReceivesAction
→
associated with statin
|
0.31
|
|
effect
→
ReceivesAction
→
addressed
|
0.31
|
|
effect
→
ReceivesAction
→
blocked by the coadministration…
|
0.31
|
|
effect
→
ReceivesAction
→
dependent on the route of admin…
|
0.31
|
|
effect
→
ReceivesAction
→
induced
|
0.31
|
|
effect
→
ReceivesAction
→
selected
|
0.31
|
|
effect
→
ReceivesAction
→
exaggerated
|
0.31
|
|
effect
→
ReceivesAction
→
offset by increased rate of cer…
|
0.30
|
|
effect
→
ReceivesAction
→
associated with cannabi
|
0.30
|
|
effect
→
ReceivesAction
→
caused by radiation
|
0.30
|
|
effect
→
ReceivesAction
→
compared
|
0.30
|
|
effect
→
ReceivesAction
→
demonstrated in vitro
|
0.30
|
|
effect
→
ReceivesAction
→
discussed in greater detail
|
0.30
|
|
effect
→
ReceivesAction
→
experienced by the user
|
0.30
|
|
effect
→
ReceivesAction
→
magnified
|
0.30
|
|
effect
→
ReceivesAction
→
overlooked
|
0.30
|
|
effect
→
ReceivesAction
→
associated with the use of cycl…
|
0.29
|
|
effect
→
ReceivesAction
→
seen in cat
|
0.29
|
|
effect
→
ReceivesAction
→
produced
|
0.29
|
|
effect
→
ReceivesAction
→
multiplied
|
0.29
|
|
effect
→
ReceivesAction
→
prescribed for child
|
0.29
|
|
effect
→
ReceivesAction
→
mixed with alcohol
|
0.29
|
|
effect
→
ReceivesAction
→
assessed by coronary angiography
|
0.29
|
|
effect
→
ReceivesAction
→
balanced
|
0.29
|
|
effect
→
ReceivesAction
→
classified as low risk
|
0.29
|
|
effect
→
ReceivesAction
→
corroborated by similar findings
|
0.29
|
|
effect
→
ReceivesAction
→
discovered by accident
|
0.29
|
|
effect
→
ReceivesAction
→
reached
|
0.29
|
|
effect
→
ReceivesAction
→
repeated
|
0.29
|
|
effect
→
ReceivesAction
→
seen in woman
|
0.29
|
|
effect
→
ReceivesAction
→
shown in fig
|
0.29
|
|
effect
→
ReceivesAction
→
sustained
|
0.29
|
|
effect
→
ReceivesAction
→
separated
|
0.28
|
|
effect
→
ReceivesAction
→
touched
|
0.28
|
|
effect
→
ReceivesAction
→
underestimated
|
0.28
|
|
effect
→
ReceivesAction
→
associated with progesterone
|
0.27
|
|
effect
→
ReceivesAction
→
affected
|
0.27
|
|
effect
→
ReceivesAction
→
associated with cardiovascular …
|
0.27
|
|
effect
→
ReceivesAction
→
associated with therapy
|
0.27
|
|
effect
→
ReceivesAction
→
attenuated
|
0.27
|
|
effect
→
ReceivesAction
→
concentrated
|
0.27
|
|
effect
→
ReceivesAction
→
due to chance
|
0.27
|
|
effect
→
ReceivesAction
→
heard
|
0.27
|
|
effect
→
ReceivesAction
→
isolated
|
0.27
|
|
effect
→
ReceivesAction
→
kept in mind
|
0.27
|
|
effect
→
ReceivesAction
→
maintained in long-term follow-…
|
0.27
|
|
effect
→
ReceivesAction
→
mixed
|
0.27
|
|
effect
→
ReceivesAction
→
removed
|
0.27
|
|
effect
→
ReceivesAction
→
reversed with known antidote
|
0.27
|
|
effect
→
ReceivesAction
→
stated
|
0.27
|
|
effect
→
ReceivesAction
→
pronounced
|
0.26
|
|
effect
→
ReceivesAction
→
limited to gastric upset
|
0.26
|
|
effect
→
ReceivesAction
→
recorded
|
0.25
|
|
effect
→
ReceivesAction
→
detected
|
0.25
|
|
effect
→
ReceivesAction
→
appreciated
|
0.25
|
|
effect
→
ReceivesAction
→
assessed by b-mode ultrasonogra…
|
0.25
|
|
effect
→
ReceivesAction
→
associated with adverse drug in…
|
0.25
|
|
effect
→
ReceivesAction
→
associated with marijuana use
|
0.25
|
|
effect
→
ReceivesAction
→
associated with thc
|
0.25
|
|
effect
→
ReceivesAction
→
attributed to a hyporeninemic-h…
|
0.25
|
|
effect
→
ReceivesAction
→
attributed to inhibition of ren…
|
0.25
|
|
effect
→
ReceivesAction
→
based on the type of cancer
|
0.25
|
|
effect
→
ReceivesAction
→
beobtained by same amount of fo…
|
0.25
|
|
effect
→
ReceivesAction
→
caught
|
0.25
|
|
effect
→
ReceivesAction
→
caused by some cancer treatments
|
0.25
|
|
effect
→
ReceivesAction
→
checked
|
0.25
|
|
effect
→
ReceivesAction
→
checked before departure
|
0.25
|
|
effect
→
ReceivesAction
→
combined with cannabis
|
0.25
|
|
effect
→
ReceivesAction
→
confirmed in human
|
0.25
|
|
effect
→
ReceivesAction
→
documented in medical journals
|
0.25
|
|
effect
→
ReceivesAction
→
examined in absolute terms
|
0.25
|
|
effect
→
ReceivesAction
→
extrapolated
|
0.25
|
|
effect
→
ReceivesAction
→
indicated in instruction
|
0.25
|
|
effect
→
ReceivesAction
→
investigated in 260
|
0.25
|
|
effect
→
ReceivesAction
→
listed in the package insert
|
0.25
|
|
effect
→
ReceivesAction
→
maximized
|
0.25
|
|
effect
→
ReceivesAction
→
mediated by action
|
0.25
|
|
effect
→
ReceivesAction
→
mediated by receptor
|
0.25
|
|
effect
→
ReceivesAction
→
mimicked
|
0.25
|
|
effect
→
ReceivesAction
→
muted
|
0.25
|
|
effect
→
ReceivesAction
→
observed in experiment
|
0.25
|
|
effect
→
ReceivesAction
→
produced by adderall
|
0.25
|
|
effect
→
ReceivesAction
→
produced by delta-9-thc
|
0.25
|
|
effect
→
ReceivesAction
→
produced by triamterene
|
0.25
|
|
effect
→
ReceivesAction
→
referred
|
0.25
|
|
effect
→
ReceivesAction
→
reflected in the ecg
|
0.25
|
|
effect
→
ReceivesAction
→
replicated
|
0.25
|
|
effect
→
ReceivesAction
→
reported in the one trial
|
0.25
|
|
effect
→
ReceivesAction
→
reversed by rimonabant
|
0.25
|
|
effect
→
ReceivesAction
→
reversed by sufficient doses of…
|
0.25
|
|
effect
→
ReceivesAction
→
seen after intravenous administ…
|
0.25
|
|
effect
→
ReceivesAction
→
solved
|
0.25
|
|
effect
→
ReceivesAction
→
studied in eight subjects
|
0.25
|
|
effect
→
ReceivesAction
→
taken along with other substanc…
|
0.25
|
|
effect
→
ReceivesAction
→
targeted
|
0.25
|
|
effect
→
ReceivesAction
→
uncovered
|
0.25
|
|
effect
→
ReceivesAction
→
difficult to deal
|
0.25
|
|
effect
→
ReceivesAction
→
thought
|
0.24
|
|
effect
→
ReceivesAction
→
common in people
|
0.24
|
|
effect
→
ReceivesAction
→
discovered in 1982
|
0.24
|
|
effect
→
ReceivesAction
→
worsened
|
0.24
|
|
effect
→
ReceivesAction
→
offset
|
0.23
|
|
effect
→
ReceivesAction
→
weakened in patient
|
0.23
|
|
effect
→
ReceivesAction
→
abused
|
0.23
|
|
effect
→
ReceivesAction
→
associated with increasing doses
|
0.23
|
|
effect
→
ReceivesAction
→
associated with each drug
|
0.21
|
|
effect
→
ReceivesAction
→
associated with fluoroquinolone…
|
0.21
|
|
effect
→
ReceivesAction
→
missed
|
0.21
|
|
effect
→
ReceivesAction
→
associated with medicine
|
0.21
|
|
effect
→
ReceivesAction
→
associated with nsaid
|
0.20
|
|
effect
→
ReceivesAction
→
countered
|
0.20
|
|
effect
→
ReceivesAction
→
easy to tolerate
|
0.20
|
|
effect
→
ReceivesAction
→
established
|
0.19
|
|
effect
→
ReceivesAction
→
observed after 6 weeks
|
0.19
|
|
effect
→
ReceivesAction
→
reported in addition
|
0.19
|
|
effect
→
ReceivesAction
→
aggravated
|
0.18
|
|
effect
→
ReceivesAction
→
associated with lipitor
|
0.18
|
|
effect
→
ReceivesAction
→
difficult to treat
|
0.18
|
|
effect
→
ReceivesAction
→
dismissed
|
0.18
|
|
effect
→
ReceivesAction
→
hidden
|
0.18
|
|
effect
→
ReceivesAction
→
listed below don't
|
0.18
|
|
effect
→
ReceivesAction
→
resolved
|
0.17
|
|
effect
→
ReceivesAction
→
associated with antibiotic
|
0.16
|
|
effect
→
ReceivesAction
→
associated with levaquin
|
0.16
|
|
effect
→
ReceivesAction
→
associated with the use of mann…
|
0.16
|
|
effect
→
ReceivesAction
→
associated with valium
|
0.16
|
|
effect
→
ReceivesAction
→
blocked by another drug
|
0.16
|
|
effect
→
ReceivesAction
→
blocked in dose-dependent manner
|
0.16
|
|
effect
→
ReceivesAction
→
caused by typical antipsychotics
|
0.16
|
|
effect
→
ReceivesAction
→
common in the elderly
|
0.16
|
|
effect
→
ReceivesAction
→
compounded
|
0.16
|
|
effect
→
ReceivesAction
→
described as disorganization
|
0.16
|
|
effect
→
ReceivesAction
→
disclosed
|
0.16
|
|
effect
→
ReceivesAction
→
downplayed
|
0.16
|
|
effect
→
ReceivesAction
→
listed on the label
|
0.16
|
|
effect
→
ReceivesAction
→
overcome for time
|
0.16
|
|
effect
→
ReceivesAction
→
produced by the rush
|
0.16
|
|
effect
→
ReceivesAction
→
questioned
|
0.16
|
|
effect
→
ReceivesAction
→
recommended
|
0.16
|
|
effect
→
ReceivesAction
→
seen in thisclass of animal
|
0.16
|
|
effect
→
ReceivesAction
→
suppressed
|
0.16
|
|
effect
→
ReceivesAction
→
seen in mouse
|
0.15
|
|
effect
→
ReceivesAction
→
reported in clinical studies
|
0.15
|
|
effect
→
ReceivesAction
→
discontinued
|
0.13
|
|
effect
→
ReceivesAction
→
detected in small clinical trial
|
0.11
|
|
effect
→
ReceivesAction
→
observed in surviving offspring
|
0.11
|
|
effect
→
ReceivesAction
→
published
|
0.11
|
|
effect
→
ReceivesAction
→
encountered
|
0.10
|
|
effect
→
ReceivesAction
→
observed at 10 mg/kg
|
0.09
|
|
effect
→
ReceivesAction
→
observed on other fertility
|
0.09
|
|
effect
→
ReceivesAction
→
observed on reproductive parame…
|
0.09
|
|
effect
→
ReceivesAction
→
mentioned by clinician
|
0.03
|
|
effect
→
ReceivesAction
→
mentioned by news media
|
0.03
|
|